publication date: Dec. 11, 2020

BSA endorses Frederick Lab’s affiliation with NCI as  recompetition of $500M 10-year contract nears

By Alexandria Carolan and Matthew Bin Han Ong

In a first procedural move of its kind, NCI asked its Board of Scientific Advisors to endorse the institute’s continuing affiliation with the Frederick National Laboratory for Cancer Research, a Federally Funded Research and Development Center.

BSA voted unanimously for NCI to initiate an RFP of a 10-year recompetition contract for operations and technical support at the Frederick National Lab. The facility, designated as one of 42 FFRDCs, is the only one dedicated solely to biomedical research.

FFRDCs receive 70% or more of their financial support from the federal government.

story3-1

 

“It is a successful program, and really what we’re talking about now is sort of the vision going forward,” NCI Director Ned Sharpless said Dec. 2 during the meeting of the BSA and National Cancer Advisory Board. “One of the most important parts of setting that new vision is reconvening this contract. It sounded like we’re just starting, but that’s actually not accurate. We’ve been at this for years already—but this is a very important midpoint today, about the successful pre-competition now targeted for 2023.”

NCI plans to award a new contract in August of 2023, said Sara Hook, director of the Office of Scientific Operations at Frederick. Leidos Biomedical Research Inc., formerly known as SAIC-Frederick, has run the lab since 1995.

The FY20 contract is estimated at more than $500 million.

“I hope … Continue reading BSA endorses Frederick Lab’s affiliation with NCI as recompetition of $500M 10-year contract nears

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.